XIFLAM Trademark

Trademark Overview

On Tuesday, June 1, 2021, a trademark application was filed for XIFLAM with the United States Patent and Trademark Office. The USPTO has given the XIFLAM trademark a serial number of 90747727. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Tuesday, May 28, 2024. This trademark is owned by OCUNEXUS THERAPEUTICS, INC.. The XIFLAM trademark is filed in the Pharmaceutical Products category with the following description:

Ocular pharmaceuticals; Pharmaceutical preparations for the treatment of eye diseases and conditions
xiflam

General Information

Serial Number90747727
Word MarkXIFLAM
Filing DateTuesday, June 1, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateTuesday, May 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 22, 2022

Trademark Statements

Goods and ServicesOcular pharmaceuticals; Pharmaceutical preparations for the treatment of eye diseases and conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 25, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOCUNEXUS THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameOCUNEXUS THERAPEUTICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events

Event DateEvent Description
Friday, June 4, 2021NEW APPLICATION ENTERED
Wednesday, August 25, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 14, 2022ASSIGNED TO EXAMINER
Thursday, February 17, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 2, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 22, 2022PUBLISHED FOR OPPOSITION
Tuesday, March 22, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 17, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, November 17, 2022SOU TEAS EXTENSION RECEIVED
Thursday, November 17, 2022SOU EXTENSION 1 FILED
Thursday, November 17, 2022SOU EXTENSION 1 GRANTED
Wednesday, May 17, 2023SOU EXTENSION 2 FILED
Friday, June 30, 2023SOU EXTENSION 2 GRANTED
Saturday, November 19, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 18, 2023PETITION TO REVIVE-GRANTED
Thursday, May 18, 2023TEAS PETITION TO REVIVE RECEIVED
Thursday, May 18, 2023SOU EXTENSION RECEIVED WITH TEAS PETITION
Thursday, May 18, 2023NOTICE OF REVIVAL - E-MAILED
Wednesday, June 28, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, November 17, 2023SOU TEAS EXTENSION RECEIVED
Friday, November 17, 2023SOU EXTENSION 3 FILED
Friday, November 17, 2023SOU EXTENSION 3 GRANTED
Tuesday, November 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 5, 2023ASSIGNED TO EXAMINER
Friday, May 17, 2024SOU EXTENSION 4 FILED
Friday, May 24, 2024PETITION TO REVIVE-GRANTED
Friday, May 24, 2024NOTICE OF REVIVAL - E-MAILED
Friday, May 24, 2024TEAS PETITION TO REVIVE RECEIVED
Friday, May 24, 2024SOU EXTENSION RECEIVED WITH TEAS PETITION
Saturday, July 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 24, 2024TEAS PETITION TO REVIVE RECEIVED
Tuesday, May 28, 2024SOU EXTENSION 4 GRANTED
Wednesday, May 29, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

xiflam diseases conditions treatment preparations pharmaceuticals pharmaceutical ocular